COURT DEFERS TO FDA ON WHETHER COMPANY'S ACTIONS INFRINGE DEVICE PATENT Nexell Therapeutics v. Amcell Corp. | Secondary Sources | Westlaw

COURT DEFERS TO FDA ON WHETHER COMPANY'S ACTIONS INFRINGE DEVICE PATENT Nexell Therapeutics v. Amcell Corp. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, COURT DEFERS TO FDA ON WHETHER COMPANY'S ACTIONS INFRINGE DEVICE PATENT Nexell Therapeutics v. Amcell Corp., Secondary Sources
Skip Page Header

COURT DEFERS TO FDA ON WHETHER COMPANY'S ACTIONS INFRINGE DEVICE PATENT Nexell Therapeutics v. Amcell Corp.

7 No. 22 ANIPLR 14Andrews Intellectual Property Litigation Reporter (Approx. 4 pages)

COURT DEFERS TO FDA ON WHETHER COMPANY'S ACTIONS INFRINGE DEVICE PATENT Nexell Therapeutics v. Amcell Corp.

7 No. 22 ANIPLR 14Andrews Intellectual Property Litigation Reporter (Approx. 4 pages)

7 No. 22 Andrews Intell. Prop. Litig. Rep. 14
Andrews Intellectual Property Litigation Reporter
May 30, 2001
Patent Infringement
Copyright (c) 2001 Andrews Publications

COURT DEFERS TO FDA ON WHETHER COMPANY'S ACTIONS INFRINGE DEVICE PATENT

Nexell Therapeutics v. Amcell Corp.

When is a company making a new medical device available to clinicians for research required by the FDA and when is it improperly giving away the device to develop brand loyalty so that it can generate sales for the device once the patent expires on a...
End of Document© 2023 Thomson Reuters. No claim to original U.S. Government Works.